---
title: "Norgestrel - Postmenopausal Osteoporosis"
sidebar: mydoc_sidebar
permalink: db09389-mesh-d015663-1.html
toc: false 
---


Path ID: `DB09389_MESH_D015663_1`
{% include image.html url="images/db09389-mesh-d015663-1.png" file="db09389-mesh-d015663-1.png" alt="db09389-mesh-d015663-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:D009644">MESH:D009644 </a> | Norgestrel | Drug |
| <a href="https://identifiers.org/MESH:D015663">MESH:D015663 </a> | Postmenopausal osteoporosis | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Norgestrel | TREATS | Postmenopausal Osteoporosis |
|---------|-----------|---------|

Comment: Norgestrel is composed of a racemic mixture of two stereoisomers, dextronorgestrel and levonorgestrel. However, only the levorotary enantiomer (levonorgestrel) is biologically active. Norgestrel is prescribed in combination with estradiol as a hormone therapy during menopause to prevent osteoporosis and in this case estradiol is the acive drug that prevents oseoporosis, while norgestrel is added for the protection of the endometrium

Reference: 
  - [https://go.drugbank.com/drugs/DB00367#BE0000557](https://go.drugbank.com/drugs/DB00367#BE0000557)
  - [https://en.wikipedia.org/wiki/Norgestrel#Medical_uses](https://en.wikipedia.org/wiki/Norgestrel#Medical_uses)
